Selected research
Industry Research
TB Vaccines Industry Research Report 2026
Market perspective
The global TB Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for TB Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for TB Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for TB Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of TB Vaccines include China National Biotec Group, Sanofi Pasteur, Merck & Co.,Inc, Statens Serum Institut, Serum Institute, Japan BCG Laboratory, InterVax Ltd, India Pvt. Ltd and GreenSignal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global TB Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
TB Vaccines Market by Company
China National Biotec Group
Sanofi Pasteur
Merck & Co.,Inc
Statens Serum Institut
Serum Institute
Japan BCG Laboratory
InterVax Ltd
India Pvt. Ltd
GreenSignal
Bio Pharma Limited
TB Vaccines Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
TB Vaccines Segment by Application
Private Clinics
Research Institutes
Hospitals
TB Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TB Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TB Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TB Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of TB Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of TB Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immunotherapeutic Vaccines
- Booster Vaccines
- Others
Applications
- Private Clinics
- Research Institutes
- Hospitals
Companies covered
- China National Biotec Group
- Sanofi Pasteur
- Merck & Co.,Inc
- Statens Serum Institut
- Serum Institute
- Japan BCG Laboratory
- InterVax Ltd
- India Pvt. Ltd
- GreenSignal
- Bio Pharma Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global TB Vaccines Market Size (2021-2032)
- 2.2.2 Global TB Vaccines Sales (2021-2032)
- 2.2.3 Global TB Vaccines Market Average Price (2021-2032)
- 2.3 TB Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Immunotherapeutic Vaccines
- 2.3.3 Booster Vaccines
- 2.3.4 Others
- 2.4 TB Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Private Clinics
- 2.4.3 Research Institutes
- 2.4.4 Hospitals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global TB Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global TB Vaccines Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global TB Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global TB Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global TB Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of TB Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of TB Vaccines, Product Type & Application
- 3.8 Global Manufacturers of TB Vaccines, Established Date
- 3.9 Global TB Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 China National Biotec Group
- 4.1.1 China National Biotec Group Company Information
- 4.1.2 China National Biotec Group Business Overview
- 4.1.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 China National Biotec Group TB Vaccines Product Portfolio
- 4.1.5 China National Biotec Group Recent Developments
- 4.2 Sanofi Pasteur
- 4.2.1 Sanofi Pasteur Company Information
- 4.2.2 Sanofi Pasteur Business Overview
- 4.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Pasteur TB Vaccines Product Portfolio
- 4.2.5 Sanofi Pasteur Recent Developments
- 4.3 Merck & Co.,Inc
- 4.3.1 Merck & Co.,Inc Company Information
- 4.3.2 Merck & Co.,Inc Business Overview
- 4.3.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck & Co.,Inc TB Vaccines Product Portfolio
- 4.3.5 Merck & Co.,Inc Recent Developments
- 4.4 Statens Serum Institut
- 4.4.1 Statens Serum Institut Company Information
- 4.4.2 Statens Serum Institut Business Overview
- 4.4.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Statens Serum Institut TB Vaccines Product Portfolio
- 4.4.5 Statens Serum Institut Recent Developments
- 4.5 Serum Institute
- 4.5.1 Serum Institute Company Information
- 4.5.2 Serum Institute Business Overview
- 4.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Serum Institute TB Vaccines Product Portfolio
- 4.5.5 Serum Institute Recent Developments
- 4.6 Japan BCG Laboratory
- 4.6.1 Japan BCG Laboratory Company Information
- 4.6.2 Japan BCG Laboratory Business Overview
- 4.6.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Japan BCG Laboratory TB Vaccines Product Portfolio
- 4.6.5 Japan BCG Laboratory Recent Developments
- 4.7 InterVax Ltd
- 4.7.1 InterVax Ltd Company Information
- 4.7.2 InterVax Ltd Business Overview
- 4.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 InterVax Ltd TB Vaccines Product Portfolio
- 4.7.5 InterVax Ltd Recent Developments
- 4.8 India Pvt. Ltd
- 4.8.1 India Pvt. Ltd Company Information
- 4.8.2 India Pvt. Ltd Business Overview
- 4.8.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 India Pvt. Ltd TB Vaccines Product Portfolio
- 4.8.5 India Pvt. Ltd Recent Developments
- 4.9 GreenSignal
- 4.9.1 GreenSignal Company Information
- 4.9.2 GreenSignal Business Overview
- 4.9.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GreenSignal TB Vaccines Product Portfolio
- 4.9.5 GreenSignal Recent Developments
- 4.10 Bio Pharma Limited
- 4.10.1 Bio Pharma Limited Company Information
- 4.10.2 Bio Pharma Limited Business Overview
- 4.10.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bio Pharma Limited TB Vaccines Product Portfolio
- 4.10.5 Bio Pharma Limited Recent Developments
5 Global TB Vaccines Market Scenario by Region
- 5.1 Global TB Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global TB Vaccines Sales by Region: 2021-2032
- 5.2.1 Global TB Vaccines Sales by Region: 2021-2026
- 5.2.2 Global TB Vaccines Sales by Region: 2027-2032
- 5.3 Global TB Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global TB Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global TB Vaccines Revenue by Region: 2027-2032
- 5.4 North America TB Vaccines Market Facts & Figures by Country
- 5.4.1 North America TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America TB Vaccines Sales by Country (2021-2032)
- 5.4.3 North America TB Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe TB Vaccines Market Facts & Figures by Country
- 5.5.1 Europe TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe TB Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe TB Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific TB Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific TB Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific TB Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America TB Vaccines Market Facts & Figures by Country
- 5.7.1 South America TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America TB Vaccines Sales by Country (2021-2032)
- 5.7.3 South America TB Vaccines Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa TB Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa TB Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa TB Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa TB Vaccines Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global TB Vaccines Sales by Type (2021-2032)
- 6.1.1 Global TB Vaccines Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global TB Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global TB Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global TB Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global TB Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global TB Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global TB Vaccines Sales by Application (2021-2032)
- 7.1.1 Global TB Vaccines Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global TB Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global TB Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global TB Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global TB Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global TB Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 TB Vaccines Value Chain Analysis
- 8.1.1 TB Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 TB Vaccines Production Mode & Process
- 8.2 TB Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 TB Vaccines Distributors
- 8.2.3 TB Vaccines Customers
9 Global TB Vaccines Analyzing Market Dynamics
- 9.1 TB Vaccines Industry Trends
- 9.2 TB Vaccines Industry Drivers
- 9.3 TB Vaccines Industry Opportunities and Challenges
- 9.4 TB Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst